Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rye

Showing results (151-160 of 218) with videos related to

Pageof 22
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 4, 2012
Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug classDonald L Bliwise, Lynn Marie Trotti, Anthony G Wilson, et al.
Oncotarget|March 17, 2018
APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancerCaroline K Søgaard, Siver A Moestue, Morten B Rye, et al.
Autonomic Neuroscience : Basic & Clinical|September 14, 2007
Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based studyRoumiana S Boneva, Michael J Decker, Elizabeth M Maloney, et al.
Science Translational Medicine|November 24, 2012
Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptorsDavid B Rye, Donald L Bliwise, Kathy Parker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodiesA I Levey, S M Hersch, D B Rye, et al.
Sleep Medicine|November 22, 2008
Correlates of PLMs variability over multiple nights and impact upon RLS diagnosisLynn Marie Trotti, Donald L Bliwise, Sophia A Greer, et al.
Oncotarget|December 29, 2016
A novel non-canonical Wnt signature for prostate cancer aggressivenessElise Sandsmark, Ailin Falkmo Hansen, Kirsten M Selnæs, et al.
Annals of Neurology|June 1, 1997
Presenilin-1 protein expression in familial and sporadic Alzheimer's diseaseA I Levey, C J Heilman, J J Lah, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2013
Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primatesJennifer C Felger, Jiyoung Mun, Heather L Kimmel, et al.
Breast Cancer Research : BCR|June 24, 2022
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survivalChristine Aaserød Pedersen, Maria Dung Cao, Thomas Fleischer, et al.
Pageof 22

Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
Movement Disorders : Official Journal of the Movement Disorder Society|July 4, 2012
Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug classDonald L Bliwise, Lynn Marie Trotti, Anthony G Wilson, et al.
Oncotarget|March 17, 2018
APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancerCaroline K Søgaard, Siver A Moestue, Morten B Rye, et al.
Autonomic Neuroscience : Basic & Clinical|September 14, 2007
Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based studyRoumiana S Boneva, Michael J Decker, Elizabeth M Maloney, et al.
Science Translational Medicine|November 24, 2012
Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptorsDavid B Rye, Donald L Bliwise, Kathy Parker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodiesA I Levey, S M Hersch, D B Rye, et al.
Sleep Medicine|November 22, 2008
Correlates of PLMs variability over multiple nights and impact upon RLS diagnosisLynn Marie Trotti, Donald L Bliwise, Sophia A Greer, et al.
Oncotarget|December 29, 2016
A novel non-canonical Wnt signature for prostate cancer aggressivenessElise Sandsmark, Ailin Falkmo Hansen, Kirsten M Selnæs, et al.
Annals of Neurology|June 1, 1997
Presenilin-1 protein expression in familial and sporadic Alzheimer's diseaseA I Levey, C J Heilman, J J Lah, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2013
Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primatesJennifer C Felger, Jiyoung Mun, Heather L Kimmel, et al.
Breast Cancer Research : BCR|June 24, 2022
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survivalChristine Aaserød Pedersen, Maria Dung Cao, Thomas Fleischer, et al.
Pageof 22